E-LIB Suche - Ergebnisse für: Foley, Peter

1

630 - Efficacy comparison of targeted systemic monotherapie..:

Silverberg, Jonathan I ; Bieber, Thomas ; Paller, Amy...
British Journal of Dermatology. 191 (2024) Supplement_2 - p. , 2024

Link: https://doi.org/10.1093/..

2

Deucravacitinib onset of action and maintenance of response..:

Korman, Neil J. ; Warren, Richard B. ; Bagel, Jerry...
Journal of Dermatological Treatment. 35 (2024) 1 - p. , 2024

Link: https://doi.org/10.1080/..

3

52238 Updated integrated safety analysis of ritlecitinib ov..:

Senna, Maryanne ; Foley, Peter ; Wiseman, Marni...
Journal of the American Academy of Dermatology. 91 (2024) 3 - p. AB96 , 2024

Link: https://doi.org/10.1016/..

4

Deucravacitinib in moderate‐to‐severe plaque psoriasis: Poo..:

Strober, Bruce ; Blauvelt, Andrew ; Warren, Richard B....
Journal of the European Academy of Dermatology and Venereology. 38 (2024) 8 - p. 1543-1554 , 2024

Link: https://doi.org/10.1111/..

5

Fatigue in early multiple sclerosis; MRI metrics of neuroin..:

Meijboom, Rozanna ; Foley, Peter ; MacDougall, Niall...
Brain Communications. , 2024

Link: https://doi.org/10.1093/..

6

Direct and Indirect Effect of Guselkumab on Anxiety, Depres..:

Armstrong, April W. ; Foley, Peter ; Liu, Yan...
Dermatology and Therapy. 14 (2024) 9 - p. 2577-2589 , 2024

Link: https://doi.org/10.1007/..

7

52661 Bimekizumab 4-year maintenance of responses in Week 1..:

Blauvelt, Andrew ; Foley, Peter ; Langley, Richard G....
Journal of the American Academy of Dermatology. 91 (2024) 3 - p. AB23 , 2024

Link: https://doi.org/10.1016/..

8

Bimekizumab Versus Secukinumab Continuous Maintenance of PA..:

Merola, Joseph ; Conrad, Curdin ; Foley, Peter...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 2 - p. s403 , 2024

Link: https://doi.org/10.25251..

9

Improved sleep parallels improvements in atopic dermatitis ..:

Merola, Joseph F. ; Chiou, Albert S. ; During, Emmanuel...
Journal of the American Academy of Dermatology. , 2024

Link: https://doi.org/10.1016/..

10

A global perspective on the treatment and maintenance of ma..:

Fluhr, Joachim W. ; Alexis, Andrew F. ; Andriessen, Anneke...
International Journal of Dermatology. , 2024

Link: https://doi.org/10.1111/..

11

661 - Efficacy and safety of amlitelimab, an anti-OX40 liga..:

Weidinger, Stephan ; Blauvelt, Andrew ; Papp, Kim...
British Journal of Dermatology. 191 (2024) Supplement_2 - p. , 2024

Link: https://doi.org/10.1093/..

12

Bimekizumab Efficacy Through 3 Years in Patients with Moder..:

Lebwohl, Mark ; Strober, Bruce ; Foley, Peter...
SKIN The Journal of Cutaneous Medicine. 8 (2024) 1 - p. s307 , 2024

Link: https://doi.org/10.25251..

13

Bimekizumab 3-year Safety and Tolerability in Moderate to S..:

Lebwohl, Mark ; Strober, Bruce ; Langley, Richard G....
SKIN The Journal of Cutaneous Medicine. 8 (2024) 1 - p. s305 , 2024

Link: https://doi.org/10.25251..

14

Dupilumab for chronic actinic dermatitis: A case series and..:

Holmes, Zachary ; Foley, Peter ; Baker, Chris.
Australasian Journal of Dermatology. 65 (2024) 3 - p. 287-291 , 2024

Link: https://doi.org/10.1111/..

15

Brain connectivity changes underlying depression and fatigu..:

Kampaite, Agniete ; Gustafsson, Rebecka ; York, Elizabeth N....
PLOS ONE. 19 (2024) 3 - p. e0299634 , 2024

Link: https://doi.org/10.1371/..